Cov nqi kho mob hauv nroog City Therapeutics nce $ 200 lab IPO, pib ua lag luam ntawm Nasdaq ua CTY
CAMBRIDGE, Mass. — City Therapeutics, ib lub tuam txhab biotechnology theem kho mob uas tsim cov tshuaj kho mob RNA interference (RNAi) tiam tom ntej, tau tshaj tawm rau yav tsaus ntuj ntawm lub Kaum Hli 15 tus nqi ntawm nws qhov kev muab khoom rau pej xeem thawj zaug: 11,111,111 feem ntawm cov khoom lag luam ntawm $ 18.00 ib feem, rau cov nyiaj tau los kwv yees li $ 200.0 lab ua ntej kev txo nqi, cov nqi commission thiab cov nuj nqis muab. Cov neeg sau npe tau tso cai 30-hnub xaiv los yuav txog li 1,666,666 feem ntxiv.
Cov feem tau pib ua lag luam ntawm Nasdaq Global Market thaum Lub Kaum Hli 16 nyob rau hauv lub ticker CTY, thiab qhov kev muab yuav kaw rau Lub Kaum Hli 19, 2026. Goldman Sachs, Jefferies thiab Stifel yog cov thawj coj ua ke, nrog Oppenheimer kuj ua tus thawj coj ua ke.
Lub tuam txhab City Therapeutics muaj lub hauv paus nyob hauv Cambridge, Massachusetts, thiab tab tom tsim cov tshuaj RNAi tiam tom ntej.
Qhov chaw: GSM · Tebchaws Meskas (Qhov kev tshaj tawm lus Askiv · Qhov kev tshaj tawm lus Suav qub)
Duab: City Therapeutics公司官方标志 / City Therapeutics official logo
